Speciality Medicines Ltd finalized a commercial arrangement with an international entity for distribution of pharmaceutical products.
The deal has an approximate value of USD 2 million (₹18.8 crores) and is expected to enhance distribution network and revenue visibility.
The transaction is not a related party transaction, with no promoter or group company interest.